Exponent, Inc. $EXPO Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. lessened its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 1.0% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 520,131 shares of the business services provider's stock after selling 5,247 shares during the quarter. Charles Schwab Investment Management Inc. owned 1.02% of Exponent worth $42,162,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Whipplewood Advisors LLC boosted its stake in shares of Exponent by 5,333.3% in the 1st quarter. Whipplewood Advisors LLC now owns 326 shares of the business services provider's stock valued at $26,000 after buying an additional 320 shares during the period. UMB Bank n.a. boosted its stake in shares of Exponent by 859.1% in the 1st quarter. UMB Bank n.a. now owns 633 shares of the business services provider's stock valued at $51,000 after buying an additional 567 shares during the period. Johnson Financial Group Inc. purchased a new position in shares of Exponent in the 4th quarter valued at about $59,000. Bessemer Group Inc. boosted its stake in shares of Exponent by 103.3% in the 1st quarter. Bessemer Group Inc. now owns 681 shares of the business services provider's stock valued at $55,000 after buying an additional 346 shares during the period. Finally, LRI Investments LLC boosted its stake in shares of Exponent by 30.4% in the 4th quarter. LRI Investments LLC now owns 1,460 shares of the business services provider's stock valued at $130,000 after buying an additional 340 shares during the period. Hedge funds and other institutional investors own 92.37% of the company's stock.

Exponent Stock Performance

Shares of EXPO traded up $2.00 during midday trading on Friday, hitting $72.48. The company had a trading volume of 70,205 shares, compared to its average volume of 320,530. The company's 50-day simple moving average is $72.91 and its 200-day simple moving average is $78.21. The firm has a market capitalization of $3.66 billion, a P/E ratio of 36.25 and a beta of 0.89. Exponent, Inc. has a 1 year low of $63.81 and a 1 year high of $115.75.

Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.04. The business had revenue of $132.87 million during the quarter, compared to analysts' expectations of $130.82 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%.The business's quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.57 EPS. Equities analysts predict that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Exponent Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 19th. Stockholders of record on Friday, September 5th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Friday, September 5th. Exponent's dividend payout ratio (DPR) is 60.00%.

Insider Transactions at Exponent

In other news, VP Joseph Sala sold 1,595 shares of the firm's stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total transaction of $112,670.80. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Catherine Corrigan sold 4,896 shares of the firm's stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $71.09, for a total value of $348,056.64. Following the sale, the chief executive officer directly owned 81,342 shares in the company, valued at $5,782,602.78. This trade represents a 5.68% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 8,064 shares of company stock valued at $582,981. Corporate insiders own 1.60% of the company's stock.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.